Lochlin Cravey, MS

Hailing from Orange Park (pronounced “arnge park”) Florida, I earned my Bachelor of Science in Biology from the University of Florida in 2016 and my Master of Science in 2021 in Biochemistry and Molecular Biology.

I’ve spent just shy of the last decade supporting and championing AAV gene therapy development in both academic and industry settings at all phases of the drug development life cycle from initial pre-clinical validation studies all the way through to clinical diagnostics for first in-human doses.